Please login to the form below

Not currently logged in

GSK to restructure Waterford plant

GSK to meet with staff at Irish plant about restructure plans

GlaxoSmithKline (GSK) is set to reveal the extent of the restructuring of its West Waterford, Ireland, plant following a business review.

The company has called the plant's 700 workers to meet with management at 3pm today to discuss what are understood to be details of restructuring at the site.

GSK told PMLiVE that it would not comment until after the meeting had taken place.

Earlier this year the company announced it was divesting a number of brands including Solpadeine, which is manufactured in the plant.

7th July 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....